INBRIJA
Total Payments
$6.4M
Transactions
32,747
Doctors
6,308
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $243,264 | 2,200 | 1,219 |
| 2023 | $524,424 | 4,933 | 1,980 |
| 2022 | $387,448 | 4,627 | 1,826 |
| 2021 | $822,546 | 4,618 | 1,645 |
| 2020 | $1.3M | 4,238 | 1,512 |
| 2019 | $3.1M | 12,131 | 3,583 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5.0M | 16,235 | 79.0% |
| Consulting Fee | $609,841 | 208 | 9.6% |
| Travel and Lodging | $364,339 | 1,631 | 5.7% |
| Food and Beverage | $360,427 | 14,558 | 5.7% |
| Education | $686.29 | 115 | 0.0% |
Top Doctors Receiving Payments for INBRIJA — Page 9
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Neurology | Durham, NC | $1,395 | 1 |
| , MD | Neurology | San Francisco, CA | $1,391 | 2 |
| , M.D | Neurology | Henrico, VA | $1,365 | 1 |
| , M.D | Specialist | New York, NY | $1,365 | 1 |
| , MD | Neurological Surgery | Tulsa, OK | $1,365 | 1 |
| , MD, PHD | Neurology | Poughkeepsie, NY | $1,365 | 1 |
| , M.D., PH.D | Neurology | Nashville, TN | $1,277 | 8 |
| Patrick Grogan | Neurology | Lackland A F B, TX | $1,257 | 67 |
| , MD | Diagnostic Neuroimaging | Milwaukee, WI | $1,116 | 49 |
| , DO | Neurology | Forest Hills, NY | $1,076 | 10 |
| , M.D | Neurology | Birmingham, AL | $1,042 | 70 |
| , M.D | Neurology | Washington, PA | $1,032 | 37 |
| , M.D | Neurology | San Marcos, TX | $1,028 | 53 |
| , MD | Neurology | Downey, CA | $1,027 | 78 |
| , M.D | Neurology | Birmingham, AL | $1,022 | 59 |
| , MD | Specialist | Birmingham, AL | $1,012 | 59 |
| , MD | Neurology | Los Gatos, CA | $969.92 | 53 |
| , N.P | Family | Plainview, NY | $950.00 | 1 |
| , M.D | Neurology | Houston, TX | $937.63 | 44 |
| , MD | Neurology | Downey, CA | $935.26 | 67 |
| , M.D | Neurology | Scottsdale, AZ | $923.60 | 55 |
| Daniel Hyun | — | San Antonio, TX | $921.41 | 39 |
| , MD | Internal Medicine | Baton Rouge, LA | $870.94 | 43 |
| , DO | Neurology | Henderson, NV | $870.61 | 27 |
| , M.D | Neurology | Miami, FL | $869.42 | 42 |
Ad
Manufacturing Companies
- Acorda Therapeutics, Inc $6.3M
- Merz Pharmaceuticals, LLC $53,687
Product Information
- Type Drug
- Total Payments $6.4M
- Total Doctors 6,308
- Transactions 32,747
About INBRIJA
INBRIJA is a drug associated with $6.4M in payments to 6,308 healthcare providers, recorded across 32,747 transactions in the CMS Open Payments database. The primary manufacturer is Acorda Therapeutics, Inc.
Payment data is available from 2019 to 2024. In 2024, $243,264 was paid across 2,200 transactions to 1,219 doctors.
The most common payment nature for INBRIJA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5.0M, 79.0% of total).